Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'

Go back to Johnson & Johnson (JNJ) Shares Dip After Revenue Miss, Suspended COVID Vaccine Sales Guidance; Results Seen as 'Mixed'
Johnson & Johnson (NYSE: JNJ) Delayed: 275.23 --0 (-0%)
Previous Close $275.23    52 Week High $126.07 
Open $275.23    52 Week Low $94.28 
Day High $275.23    P/E 57.22 
Day Low $275.23    EPS $4.81 
Volume 27,641